Connect with us

Hi, what are you looking for?

press release

HemaTerra Takes Confusion and Concern Out of Quality Control Plans

/EINPresswire.com/ HemaComply takes the confusion and concern out of managing QC plans by following configured processes and providing a single location for information.

HemaTerra Technologies, an operational software systems provider to organizations that collect blood, platelets, plasma and other biologic products, announced the implementation of HemaComply, a web-based Quality Control (QC) management system. HemaComply takes the confusion and concern out of managing QC plans by following configured processes and providing a single location for information. From beginning to end, each step in the QC process is recorded, acknowledged and completed before becoming part of the QC plan history.

“The timing could not be better for HemaComply,” said Marian Garrard, COO Blood Services for The Blood and Tissue Center of Central Texas. “QC plan management and resources will certainly benefit from having automated processes and centralized information. This is the first system I’ve seen that will enable us to configure workflow into our footprint, and for each facet of our QC plan. No part of the process is left to chance, and our team remains on task with the help of notifications and alerts that are part of this system.”

HemaComply’s simple point-and-click interface helps blood centers easily achieve consistent product sampling and qualification, as well as successful execution of their QC plan. HemaComply assembles the information for blood centers — from every location and device — and then organizes it into navigable categories. This one central system enables blood centers to input, monitor and retrieve information, as well as make changes to their QC plan, based on timely reports.

“This system is a true workhorse and does a great job of aggregating data and QC plan performance,” said HemaTerra President and CEO Todd Collins. “HemaComply does away with cumbersome spreadsheets and assembling various data files to create QC audit reports. The information you need (and rely on) is literally at your fingertips at any time, and from any computer or smartphone.”

HemaTerra collaborated with key industry organizations that share the challenge of maintaining a consistent and effective QC plan. Their insight clarified a very complex process, and HemaTerra appreciates the support received from the following blood centers:
• The Blood and Tissue Center of Central Texas, Austin, Texas;
• Carter BloodCare, Bedford, Texas;
• Coastal Bend Blood Center, Corpus Christi, Texas;
• Gulf Coast Regional Blood Center, Houston, Texas; and
• LifeShare Blood Centers, Shreveport, La.

With development previously announced in January 2013, HemaComply is implementing in two blood centers and is planned for several more.

About HemaTerra Technologies
HemaTerra Technologies works exclusively with organizations that collect blood, platelets, plasma and other biologic products. Its technology brings choices back to blood and plasma centers. HemaTerra provides operational software systems that have more features, more power and cost less: HemaConnect, donor recruitment CRM; HemaControl, collections, demand & inventory management; HemaComply, quality control management; and HemaMobile, smartphone applications.

Media Contact:
Kathleen Taormina
HemaTerra Technologies
904-288-5999
http://www.hematerra.com

Press release courtesy of Online PR Media: http://bit.ly/10nVBDi

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...